FDA clears DxNow ’ s sperm separation device

Medical device developer DxNow said today it won FDA 510(k) clearance for its ZyMōt ICSI and ZyMōt multi sperm separation devices designed for use in assisted reproductive technology procedures. The newly cleared devices from the Gaithersburg, Md.-based company are designed for preparing motile sperm from semen for use in the treatment of infertile couples by intracytoplasmic sperm injection, intrauterine insemination and in vitro fertilization procedures. “We are excited to announce the achievement of this significant milestone in our company’s evolution. This announcement follows CE certification and the introduction of our sperm separation devices in Turkey and several European, Latin American and Asian countries. We have developed devices that make ART procedures faster and less demanding for reproductive medicine professionals. Equally important, we are offering a new pathway for enabling the selection of stronger and healthier sperm, with the ultimate goal of supporting infertile couples striving to conceive,” co-founder &CEO Bill Sharp said in a press release. DxNow said the devices are the first of their kind to win clearance and approval in the US. The systems are intended to simulate the cervical and uterine patheway to facilitate the separation and preparation of highly-motile sperm with normal morphology for use in ART procedures. “This is an outstanding validation of our core technology platforms. It is very gratifying to k...
Source: Mass Device - Category: Medical Devices Authors: Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance dxnow Source Type: news

Related Links:

Condition:   Infertility Intervention:   Other: Medium Supplemented with Latrunculin A Sponsor:   Ibn Sina Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Infertility Intervention:   Other: Medium Supplemented with Cytochalasin D Sponsor:   Ibn Sina Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Infertility, Female;   Infertility;   Genital Diseases, Male;   Genital Diseases, Female;   Progesterone;   Dydrogesterone;   Hormones;   Hormones, Hormone Substitutes, and Hormone Antagonists;   Physiological Effects of Drugs;   Progestins Interventions:   Drug: Dydrogesterone Oral Tablet;   Drug: Micronized progesterone;   Drug: Placebo Dydrogesterone oral tablet;   Drug: Placebo Micronized progesterone Sponsors:   CRG UZ Bru...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Infertility Intervention:   Other: Medium Supplemented with Cytochalasin D Sponsor:   Ibn Sina Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Infertility, Female;   Infertility;   Genital Diseases, Male;   Genital Diseases, Female;   Progesterone;   Dydrogesterone;   Hormones;   Hormones, Hormone Substitutes, and Hormone Antagonists;   Physiological Effects of Drugs;   Progestins Interventions:   Drug: Dydrogesterone Oral Tablet;   Drug: Micronized progesterone;   Drug: Placebo Dydrogesterone oral tablet;   Drug: Placebo Micronized progesterone Sponsors:   CRG UZ Bru...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Infertility Intervention:   Other: Medium Supplemented with Cytochalasin D Sponsor:   Ibn Sina Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Infertility, Female;   Infertility;   Genital Diseases, Male;   Genital Diseases, Female;   Progesterone;   Dydrogesterone;   Hormones;   Hormones, Hormone Substitutes, and Hormone Antagonists;   Physiological Effects of Drugs;   Progestins Interventions:   Drug: Dydrogesterone Oral Tablet;   Drug: Micronized progesterone;   Drug: Placebo Dydrogesterone oral tablet;   Drug: Placebo Micronized progesterone Sponsors:   CRG UZ Bru...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Infertility Intervention:   Other: Doing ICSI I a medium supplemented with Ionomycin and Latrunculin A Sponsors:   Ibn Sina Hospital;   Banoon IVF Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Infertility Intervention:   Other: Medium Supplemented with Latrunculin B Sponsor:   Ibn Sina Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Infertility Intervention:   Other: Medium Supplemented with Chaetoglobosin A Sponsor:   Ibn Sina Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: ICSI (Intracytoplasmic Sperm Injection) | Infertility | Medical Devices | Middle East Health | Reproduction Medicine | Turkey Health | USA Health